<< Researchers have found that increasing paternal age is significantly associated with increased rates of spontaneous abortion | Structural alterations in breast stromal and epithelial DNA >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский

FDA develops cost-effective way to identify bioterror agents used in hoax incidents

Published on August 3, 2006 at 3:31 PM · No Comments

Researchers at the Food and Drug Administration (FDA) National Center for Toxicological Research (NCTR) are developing a quick, cost-effective way to screen for and identify bioterror agents and other substances used in hoax incidents.

The testing method uses a technology called mass spectrometry. This technique identifies and quantifies compounds, based on the structure and chemical properties of their molecules, quickly and with a very high degree of accuracy.

The testing process works in a way similar to the FBI's fingerprint library for criminals. A researcher can take patterns generated by a mass spectrometer's analysis of a substance to be identified and compare them to a database of known substances, for immediate recognition.

"Our new technique, along with fingerprinting, offers a rapid and valuable assessment of a range of bioterror and hoax samples," said NCTR's Dr. Jon Wilkes, Ph.D., the lead author of the study. "We hope to see the testing put into place by government and industry in the near future. Anytime we can run tests more quickly, we can benefit public health and safety." NCTR will continue to build the "finger print" data base.

This project serves as a prime example of scientific work conducted under the FDA's Critical Path Initiative -- work that is intended from its conception for widespread use.

Although other testing methods, such as DNA testing, are available, they are costly and involve lengthy processes that can delay by days detection of micro-organisms that can cause disease. This new technique is very fast, taking about 7 minutes for each sample on the mass spectrometer following three to eight hours of sample preparation time. Sample preparation is beyond the scope of this paper.

Although this new test (screening technique) can not distinguish living from nonliving microbiological organisms (whether cells are dead or alive), the test can process a large number of samples rapidly. The per test cost is as little as $2 each whereas DNA methods cost from $15 to $50 per test and take from 24 hours from start to finish including sample growth or culture.

The speed and cost-effectiveness of the tests make their use feasible for FDA enforcement work as well as for industry. Researchers found that the testing method could be used to distinguish biological and chemical samples of all sorts, addressing the analytical needs of the food industry, law enforcement and military authorities as well as regulatory agencies

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading